Cargando…
Economics of the clinical management of lung cancer in France: an analysis using a Markov model
To evaluate, according to the histologic type and initial stage, the mean cost (MC) of managing patients with lung cancer and the costs of the different management phases. A Markov approach was used to model these costs, based on the management of a representative nation-wide sample of 428 patients...
Autores principales: | Chouaïd, C, Molinier, L, Combescure, C, Daurès, J P, Housset, B, Vergnenègre, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409571/ https://www.ncbi.nlm.nih.gov/pubmed/14735183 http://dx.doi.org/10.1038/sj.bjc.6601547 |
Ejemplares similares
-
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
por: Chouaïd, Christos, et al.
Publicado: (2014) -
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
por: Vergnenègre, A, et al.
Publicado: (2013) -
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)
por: LeCaer, H, et al.
Publicado: (2011) -
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
por: Heinzlef, Olivier, et al.
Publicado: (2020) -
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
por: Pujol, J-L, et al.
Publicado: (2004)